 |
27 Diseases |  |
1 Trial |
|
1 Trial |  |
100 News |  |
| «12 |
- |||||| Dupixent (dupilumab) / Sanofi, Regeneron
Enrollment open: LIBERTY ASTHMA VENTURE: Evaluation of Dupilumab in Patients With Severe Steroid Dependent Asthma (clinicaltrials.gov) - Oct 22, 2015
P3, N=150, Recruiting, Sponsor: Sanofi
Not yet recruiting --> Recruiting
- |||||||||| Dupixent (dupilumab) / Sanofi, Regeneron
New P3 trial: LIBERTY ASTHMA VENTURE: Evaluation of Dupilumab in Patients With Severe Steroid Dependent Asthma (clinicaltrials.gov) - Aug 19, 2015
P3, N=150, Not yet recruiting, Sponsor: Sanofi
- levalbuterol / Generic mfg.
Trial primary completion date, HEOR: COPD Assessment and Management Bundle Versus Usual Care (clinicaltrials.gov) - Jun 11, 2015
P=N/A, N=122, Enrolling by invitation, Sponsor: University of Illinois at Chicago
Not yet recruiting --> Recruiting Trial primary completion date: Mar 2015 --> Sep 2015
- |||||| Dupixent (dupilumab) / Sanofi, Regeneron
Enrollment open: Evaluation of Dupilumab in Patients With Persistent Asthma (Liberty Asthma Quest) (clinicaltrials.gov) - May 13, 2015
P3, N=1638, Recruiting, Sponsor: Sanofi
Trial primary completion date: Mar 2015 --> Sep 2015 Not yet recruiting --> Recruiting
- |||| Dupixent (dupilumab) / Sanofi, Regeneron
Trial completion: An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma (clinicaltrials.gov) - Apr 20, 2015
P2, N=775, Completed, Sponsor: Sanofi
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- Xopenex HFA (levalbuterol tartrate) / Sumitomo Pharma
Enrollment change, Trial termination: A Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects (clinicaltrials.gov) - Apr 18, 2015
P3, N=18, Terminated, Sponsor: Sunovion
Active, not recruiting --> Completed N=120 --> 18 | Recruiting --> Terminated
- |||||||||| Dupixent (dupilumab) / Sanofi, Regeneron
New P3 trial: Evaluation of Dupilumab in Patients With Persistent Asthma (Liberty Asthma Quest) (clinicaltrials.gov) - Apr 13, 2015
P3, N=1638, Not yet recruiting, Sponsor: Sanofi
- ||| Dupixent (dupilumab) / Sanofi, Regeneron
Enrollment closed: An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma (clinicaltrials.gov) - Nov 20, 2014
P2, N=750, Active, not recruiting, Sponsor: Sanofi
N=120 --> 18 | Recruiting --> Terminated Recruiting --> Active, not recruiting
- |||||| Xopenex HFA (levalbuterol tartrate) / Sumitomo Pharma
Enrollment open: A Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects (clinicaltrials.gov) - Jul 27, 2014
P3, N=120, Recruiting, Sponsor: Sunovion
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- levalbuterol / Generic mfg.
New P4 trial: Aerosolized Beta-Agonist Isomers in Asthma (clinicaltrials.gov) - Jun 24, 2014
P4, N=10, Completed, Sponsor: Duke University
- |||||||||| Xopenex HFA (levalbuterol tartrate) / Sumitomo Pharma
New P3 trial: A Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects (clinicaltrials.gov) - May 28, 2014
P3, N=120, Not yet recruiting, Sponsor: Sunovion
- |||| levalbuterol / Generic mfg.
Trial completion: Continuous Levalbuterol for Treatment of Status Asthmaticus in Children (clinicaltrials.gov) - Feb 22, 2014
P4, N=81, Completed, Sponsor: Children's Hospital of Philadelphia
Not yet recruiting --> Recruiting No longer recruiting --> Completed
- ||||||| levalbuterol / Generic mfg.
Trial completion: Long Term Safety Study of Levalbuterol and Racemic Albuterol in Subjects Twelve Years of Age and Older With Asthma (clinicaltrials.gov) - Feb 22, 2014
P3, N=746, Completed, Sponsor: Sunovion
No longer recruiting --> Completed No longer recruiting --> Completed
- ||| Dupixent (dupilumab) / Sanofi, Regeneron
Enrollment change: An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma (clinicaltrials.gov) - Nov 13, 2013
P2, N=750, Recruiting, Sponsor: Sanofi
No longer recruiting --> Completed N=600 --> 750
- ||||||| Xopenex HFA (levalbuterol tartrate) / Sumitomo Pharma
Trial completion: A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma (clinicaltrials.gov) - Jun 30, 2013
P3, N=198, Completed, Sponsor: Sunovion
N=600 --> 750 Active, not recruiting --> Completed
- |||| Dupixent (dupilumab) / Sanofi, Regeneron
Enrollment open: An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma (clinicaltrials.gov) - Jun 2, 2013
P2, N=750, Recruiting, Sponsor: Sanofi
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- ||||| Dupixent (dupilumab) / Sanofi, Regeneron
New P2 trial: An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma (clinicaltrials.gov) - May 13, 2013
P2, N=750, Recruiting, Sponsor: Sanofi
- ||| Dupixent (dupilumab) / Sanofi, Regeneron
Enrollment change: Efficacy, Safety, and Tolerability of Dupilumab in Patients With Persistent Moderate to Severe Eosinophilic Asthma (clinicaltrials.gov) - Nov 7, 2012
P2, N=104, Completed, Sponsor: Sanofi
Not yet recruiting --> Recruiting N=130 --> 104
- |||| Dupixent (dupilumab) / Sanofi, Regeneron
Trial completion: Efficacy, Safety, and Tolerability of Dupilumab in Patients With Persistent Moderate to Severe Eosinophilic Asthma (clinicaltrials.gov) - Nov 7, 2012
P2, N=104, Completed, Sponsor: Sanofi
N=130 --> 104 Active, not recruiting --> Completed
- ||||| levalbuterol / Generic mfg.
New P2 trial: A Study of Daily Dosing With Levalbuterol, Racemic Albuterol, and Placebo in Pediatric Subjects With Asthma (clinicaltrials.gov) - Aug 1, 2012
P2, N=146, Completed, Sponsor: Sunovion
- levalbuterol / Generic mfg.
Enrollment change: Albuterol Versus Xopenex in Treatment of Acute Asthma in the Emergency Department (ED) (clinicaltrials.gov) - Aug 14, 2011
P4, N=101, Completed, Sponsor: Phoenix Children's Hospital
Active, not recruiting --> Completed N=300 --> 101